Futurescapes: evidence expectations in the USA for comparative effectiveness research for drugs in 2020
Explore key factors influencing future expectations for the production of evidence from comparative effectiveness research for drugs in the USA in 2020 and construct three plausible future scenarios. Semistructured key informant interviews and three rounds of modified Delphi with systematic scenario...
Gespeichert in:
| Veröffentlicht in: | Journal of comparative effectiveness research 2015-08, Vol.4 (4), p.385-400 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 400 |
|---|---|
| container_issue | 4 |
| container_start_page | 385 |
| container_title | Journal of comparative effectiveness research |
| container_volume | 4 |
| creator | Messner, Donna A Mohr, Penny Towse, Adrian |
| description | Explore key factors influencing future expectations for the production of evidence from comparative effectiveness research for drugs in the USA in 2020 and construct three plausible future scenarios.
Semistructured key informant interviews and three rounds of modified Delphi with systematic scenario-building methods.
Most influential key factors were: health delivery system integration; electronic health record development; exploitation of very large databases and mixed data sources; and proactive patient engagement in research. The scenario deemed most likely entailed uneven development of large integrated health systems with pockets of increased provider risk for patient care, enhanced data collection systems, changing incentives to do comparative effectiveness research and new opportunities for evidence generation partnerships. |
| doi_str_mv | 10.2217/cer.15.6 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1704351741</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A425377156</galeid><sourcerecordid>A425377156</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-6875a5f1c56e865768ee1ea3fc14b329dcfe332f474200a801fa2d85182d4dc33</originalsourceid><addsrcrecordid>eNplkE1LAzEQhoMottSCv0AWvHhpzXe23kqxKhQ8aM8hzU7aSLu7JrtF_73ph_XgXGZCnnkHHoSuCR5SStS9hTAkYijPUJdiTgeSEXZ-mrHooH6MHziVzPlI0EvUoUIxrPCoi5bTtmkDRGtqiA8ZbH0BpYUMvmqwjWl8VcbMl1mzgmz-Ns5cFTJbbWoT0t82cc4lLk0lxJilIDDBrvZYEdrlfpdiiq_QhTPrCP1j76H59PF98jyYvT69TMazgWVCNgOZK2GEI1ZIyKVQMgcgYJizhC8YHRXWAWPUccUpxibHxBla5ILktOCFZayH7g65dag-W4iN3vhoYb02JVRt1ERhzgRRnCT09oAuzRq0L13VBGN3uB5zKphSRMi_QBuqGAM4XQe_MeFbE6x3_nXyr4nQO_TmeLtdbKA4gb-2E8APgDtK9zvX-vBKG976Ev7n_gCML5Fs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1704351741</pqid></control><display><type>article</type><title>Futurescapes: evidence expectations in the USA for comparative effectiveness research for drugs in 2020</title><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Messner, Donna A ; Mohr, Penny ; Towse, Adrian</creator><creatorcontrib>Messner, Donna A ; Mohr, Penny ; Towse, Adrian</creatorcontrib><description>Explore key factors influencing future expectations for the production of evidence from comparative effectiveness research for drugs in the USA in 2020 and construct three plausible future scenarios.
Semistructured key informant interviews and three rounds of modified Delphi with systematic scenario-building methods.
Most influential key factors were: health delivery system integration; electronic health record development; exploitation of very large databases and mixed data sources; and proactive patient engagement in research. The scenario deemed most likely entailed uneven development of large integrated health systems with pockets of increased provider risk for patient care, enhanced data collection systems, changing incentives to do comparative effectiveness research and new opportunities for evidence generation partnerships.</description><identifier>ISSN: 2042-6305</identifier><identifier>EISSN: 2042-6313</identifier><identifier>DOI: 10.2217/cer.15.6</identifier><identifier>PMID: 25730709</identifier><language>eng</language><publisher>England: Future Medicine Ltd</publisher><subject>comparative effectiveness research ; Comparative Effectiveness Research - economics ; Comparative Effectiveness Research - methods ; Comparative Effectiveness Research - trends ; data mining ; database networks ; Databases, Factual ; Delivery of Health Care ; Delphi Technique ; drug development ; Drug Discovery - economics ; Drug Discovery - methods ; Drug Discovery - trends ; Electronic Health Records ; Evidence-based medicine ; Forecasts and trends ; future scenarios ; healthcare costs ; healthcare integration ; healthcare reform ; Humans ; Interviews as Topic ; patient activism ; Patient Participation ; patient-centered outcomes research ; Pharmaceutical research ; Prescription Drugs - economics ; research partnerships ; risk-sharing ; United States</subject><ispartof>Journal of comparative effectiveness research, 2015-08, Vol.4 (4), p.385-400</ispartof><rights>Future Medicine Ltd</rights><rights>COPYRIGHT 2015 Future Medicine Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-6875a5f1c56e865768ee1ea3fc14b329dcfe332f474200a801fa2d85182d4dc33</citedby><cites>FETCH-LOGICAL-c356t-6875a5f1c56e865768ee1ea3fc14b329dcfe332f474200a801fa2d85182d4dc33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25730709$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Messner, Donna A</creatorcontrib><creatorcontrib>Mohr, Penny</creatorcontrib><creatorcontrib>Towse, Adrian</creatorcontrib><title>Futurescapes: evidence expectations in the USA for comparative effectiveness research for drugs in 2020</title><title>Journal of comparative effectiveness research</title><addtitle>J Comp Eff Res</addtitle><description>Explore key factors influencing future expectations for the production of evidence from comparative effectiveness research for drugs in the USA in 2020 and construct three plausible future scenarios.
Semistructured key informant interviews and three rounds of modified Delphi with systematic scenario-building methods.
Most influential key factors were: health delivery system integration; electronic health record development; exploitation of very large databases and mixed data sources; and proactive patient engagement in research. The scenario deemed most likely entailed uneven development of large integrated health systems with pockets of increased provider risk for patient care, enhanced data collection systems, changing incentives to do comparative effectiveness research and new opportunities for evidence generation partnerships.</description><subject>comparative effectiveness research</subject><subject>Comparative Effectiveness Research - economics</subject><subject>Comparative Effectiveness Research - methods</subject><subject>Comparative Effectiveness Research - trends</subject><subject>data mining</subject><subject>database networks</subject><subject>Databases, Factual</subject><subject>Delivery of Health Care</subject><subject>Delphi Technique</subject><subject>drug development</subject><subject>Drug Discovery - economics</subject><subject>Drug Discovery - methods</subject><subject>Drug Discovery - trends</subject><subject>Electronic Health Records</subject><subject>Evidence-based medicine</subject><subject>Forecasts and trends</subject><subject>future scenarios</subject><subject>healthcare costs</subject><subject>healthcare integration</subject><subject>healthcare reform</subject><subject>Humans</subject><subject>Interviews as Topic</subject><subject>patient activism</subject><subject>Patient Participation</subject><subject>patient-centered outcomes research</subject><subject>Pharmaceutical research</subject><subject>Prescription Drugs - economics</subject><subject>research partnerships</subject><subject>risk-sharing</subject><subject>United States</subject><issn>2042-6305</issn><issn>2042-6313</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplkE1LAzEQhoMottSCv0AWvHhpzXe23kqxKhQ8aM8hzU7aSLu7JrtF_73ph_XgXGZCnnkHHoSuCR5SStS9hTAkYijPUJdiTgeSEXZ-mrHooH6MHziVzPlI0EvUoUIxrPCoi5bTtmkDRGtqiA8ZbH0BpYUMvmqwjWl8VcbMl1mzgmz-Ns5cFTJbbWoT0t82cc4lLk0lxJilIDDBrvZYEdrlfpdiiq_QhTPrCP1j76H59PF98jyYvT69TMazgWVCNgOZK2GEI1ZIyKVQMgcgYJizhC8YHRXWAWPUccUpxibHxBla5ILktOCFZayH7g65dag-W4iN3vhoYb02JVRt1ERhzgRRnCT09oAuzRq0L13VBGN3uB5zKphSRMi_QBuqGAM4XQe_MeFbE6x3_nXyr4nQO_TmeLtdbKA4gb-2E8APgDtK9zvX-vBKG976Ev7n_gCML5Fs</recordid><startdate>20150801</startdate><enddate>20150801</enddate><creator>Messner, Donna A</creator><creator>Mohr, Penny</creator><creator>Towse, Adrian</creator><general>Future Medicine Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150801</creationdate><title>Futurescapes: evidence expectations in the USA for comparative effectiveness research for drugs in 2020</title><author>Messner, Donna A ; Mohr, Penny ; Towse, Adrian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-6875a5f1c56e865768ee1ea3fc14b329dcfe332f474200a801fa2d85182d4dc33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>comparative effectiveness research</topic><topic>Comparative Effectiveness Research - economics</topic><topic>Comparative Effectiveness Research - methods</topic><topic>Comparative Effectiveness Research - trends</topic><topic>data mining</topic><topic>database networks</topic><topic>Databases, Factual</topic><topic>Delivery of Health Care</topic><topic>Delphi Technique</topic><topic>drug development</topic><topic>Drug Discovery - economics</topic><topic>Drug Discovery - methods</topic><topic>Drug Discovery - trends</topic><topic>Electronic Health Records</topic><topic>Evidence-based medicine</topic><topic>Forecasts and trends</topic><topic>future scenarios</topic><topic>healthcare costs</topic><topic>healthcare integration</topic><topic>healthcare reform</topic><topic>Humans</topic><topic>Interviews as Topic</topic><topic>patient activism</topic><topic>Patient Participation</topic><topic>patient-centered outcomes research</topic><topic>Pharmaceutical research</topic><topic>Prescription Drugs - economics</topic><topic>research partnerships</topic><topic>risk-sharing</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Messner, Donna A</creatorcontrib><creatorcontrib>Mohr, Penny</creatorcontrib><creatorcontrib>Towse, Adrian</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of comparative effectiveness research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Messner, Donna A</au><au>Mohr, Penny</au><au>Towse, Adrian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Futurescapes: evidence expectations in the USA for comparative effectiveness research for drugs in 2020</atitle><jtitle>Journal of comparative effectiveness research</jtitle><addtitle>J Comp Eff Res</addtitle><date>2015-08-01</date><risdate>2015</risdate><volume>4</volume><issue>4</issue><spage>385</spage><epage>400</epage><pages>385-400</pages><issn>2042-6305</issn><eissn>2042-6313</eissn><abstract>Explore key factors influencing future expectations for the production of evidence from comparative effectiveness research for drugs in the USA in 2020 and construct three plausible future scenarios.
Semistructured key informant interviews and three rounds of modified Delphi with systematic scenario-building methods.
Most influential key factors were: health delivery system integration; electronic health record development; exploitation of very large databases and mixed data sources; and proactive patient engagement in research. The scenario deemed most likely entailed uneven development of large integrated health systems with pockets of increased provider risk for patient care, enhanced data collection systems, changing incentives to do comparative effectiveness research and new opportunities for evidence generation partnerships.</abstract><cop>England</cop><pub>Future Medicine Ltd</pub><pmid>25730709</pmid><doi>10.2217/cer.15.6</doi><tpages>16</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2042-6305 |
| ispartof | Journal of comparative effectiveness research, 2015-08, Vol.4 (4), p.385-400 |
| issn | 2042-6305 2042-6313 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1704351741 |
| source | MEDLINE; PubMed Central; Alma/SFX Local Collection |
| subjects | comparative effectiveness research Comparative Effectiveness Research - economics Comparative Effectiveness Research - methods Comparative Effectiveness Research - trends data mining database networks Databases, Factual Delivery of Health Care Delphi Technique drug development Drug Discovery - economics Drug Discovery - methods Drug Discovery - trends Electronic Health Records Evidence-based medicine Forecasts and trends future scenarios healthcare costs healthcare integration healthcare reform Humans Interviews as Topic patient activism Patient Participation patient-centered outcomes research Pharmaceutical research Prescription Drugs - economics research partnerships risk-sharing United States |
| title | Futurescapes: evidence expectations in the USA for comparative effectiveness research for drugs in 2020 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T16%3A38%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Futurescapes:%20evidence%20expectations%20in%20the%20USA%20for%20comparative%20effectiveness%20research%20for%20drugs%20in%202020&rft.jtitle=Journal%20of%20comparative%20effectiveness%20research&rft.au=Messner,%20Donna%20A&rft.date=2015-08-01&rft.volume=4&rft.issue=4&rft.spage=385&rft.epage=400&rft.pages=385-400&rft.issn=2042-6305&rft.eissn=2042-6313&rft_id=info:doi/10.2217/cer.15.6&rft_dat=%3Cgale_proqu%3EA425377156%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1704351741&rft_id=info:pmid/25730709&rft_galeid=A425377156&rfr_iscdi=true |